Skip to content

Clinical trials

Phase 1 Head and Neck Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Phase: Phase 1 Country / region: China Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20201
20213
20224
20235
20242
20252
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status9
Recruiting8
Completed3
Active, not recruiting2
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Yunying Medical Technology3
West China Hospital3
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.2
Corregene Biotechnology Co., Ltd2
Sichuan Baili Pharmaceutical Co., Ltd.2
AstraZeneca1
FindCure Biosciences (ZhongShan) Co., Ltd.1
Novartis Pharmaceuticals1
Pfizer1
Ruijin Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms24
Breast Neoplasms6
Carcinoma, Non-Small-Cell Lung6
Esophageal Neoplasms5
Lung Neoplasms5
Colorectal Neoplasms4
Anus Neoplasms3
Melanoma3
Nasopharyngeal Neoplasms3
Neoplasms3

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.